fbpx
QQQ
+ 1.24
303.04
+ 0.41%
DIA
+ 2.49
297.52
+ 0.83%
SPY
+ 3.11
363.56
+ 0.85%
TLT
-2.31
159.82
-1.47%
GLD
-0.51
173.33
-0.3%

Blueberries Medical CEO Resigns

October 26, 2020 1:56 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Latin American cannabis producer Blueberries Medical (CSE:BBM) (OTCQB:BBRRF) announced on Monday the resignation of CEO Camilo Villalba.

Blueberries said Villalba will remain associated with the company as a consultant.

“I see such enormous potential both with the company and medicinal cannabis sector,” said Villalba. “However, some extremely unanticipated circumstances have arisen that have forced my hand, and I am unable to carry on. We have achieved tremendous milestones so far, and I would like to thank the board for having given me this opportunity." 

Executive Chairman Christian Toro has been appointed as Interim CEO.

The board stated they deem inappropriate to appoint a new CEO in the midst of the COVID-19 pandemic.

Blueberries will now place its focus on reducing costs and preserving capital. The company started a campaign to reduce administrative costs and operational expenditures at the start of the pandemic, and plans to continue along this line until revenues from cannabis sales starts coming in.

Registration of THC Cultivars: Blueberries is a licensed producer of medical cannabis with primary operation in Colombia. The company holds licenses to commercialize, manufacture and export THC-rich products and derivatives, and is currently on track to establish operations in Argentina.

On Monday, Blueberries also announced receiving approval from the Colombian Agricultural Institute to register its nine psychoactive THC-dominant strains with the national cultivar registry.

Courtesy Image


Related Articles

Cannabis Stock Gainers And Losers From December 4, 2020

GAINERS: Empower Clinics (OTC: EPWCF) shares closed up 69.5% at $0.11 read more

Aleafia Health Presents Debuts High Potency CBD 50 Cannabis Oil

Aleafia Health Inc. (TSX: AH) (OTCQX: ALEAF) is launching high potency CBD 50 oils. The cannabis company crafted SymblTM High CBD 50 and EmblemTM CBD 50 to meet the needs of both adult-use consumers and medical patients, respectively. read more

Data: Cannabis Capital Raises Down 65% Year-Over-Year As We Enter December

The Viridian Cannabis Deal Tracker is an information service that monitors capital raise and M&A activity in the legal cannabis industry. read more

Cannabis Stock Gainers And Losers From December 3, 2020

GAINERS: iAnthus Capital Hldgs (PINK: ITHUF) shares closed up 38.51% at $0.30 read more

Gaby Buys Mankind Cannabis Dispensary For $36.5M, Confirms $8.5M Private Placement

Shares of GABY Inc. (OTCQB: GABLF) are trading up almost 6% on Thursday afternoon, after the cannabis company announced a merger with Mankind Dispensary, one of the first licensed dispensaries in California. read more